Long-term management of resistant, fistulazing Crohn's disease by ongoing 4-weekly infliximab therapy (a case report)

Schwab, Richárd; Lakatos, P; Schäfer, E; Weltner, John S.; Sáfrány, A.; A, Pap; Papp, J.

doi:10.1055/s-2005-869761

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In exceptional cases, the interval between infusions was also shortened to four to six weeks. 46 Surgery is mainly performed in selected centres and with almost the same frequency in Eastern Europe as in West European countries. The procedures performed are also similar.…”

Section: Treatment Strategy Of Ibd In Eastern Europementioning

confidence: 99%

Management of inflammatory bowel diseases in Eastern Europe

Lakatos

2006

Postgraduate Medical Journal

View full text Add to dashboard Cite

Limited data are available on the management of inflammatory bowel diseases (IBD) in East European countries. The diagnostic tools and most treatment options are also available in Eastern Europe. The diagnostic procedures commonly used became more sophisticated in the past few years, with a greater use of computed tomography/magnetic resonance imaging and serology testing; however, double contrast barium enema, enteroclysis, and endoscopy remained standard. The medical therapy and surgical strategies are also somewhat different from those applied in Western countries. In ulcerative colitis, besides mesalazine, the use of sulphasalazine is still frequent, while azathioprine is only used in a minority of patients. The use of conventional corticosteroids is common and the rate of non-colorectal cancer associated colectomies is low. In contrast, 5-aminosalicylates are still used for maintenance in Crohn's disease and azathioprine is generally less frequently given compared with Western Europe. Biological agents have also become available about five years ago, yet their use is restricted mainly to specialised centres.

show abstract

Section: Treatment Strategy Of Ibd In Eastern Europementioning

confidence: 99%

Management of inflammatory bowel diseases in Eastern Europe

Lakatos

2006

Postgraduate Medical Journal

View full text Add to dashboard Cite

show abstract

Long-term management of resistant, fistulazing Crohn's disease by ongoing 4-weekly infliximab therapy (a case report)

Cited by 1 publication

References 0 publications

Management of inflammatory bowel diseases in Eastern Europe

Management of inflammatory bowel diseases in Eastern Europe

Contact Info

Product

Resources

About